Literature DB >> 16146343

Unbiased membrane permeability parameters for gabapentin using boundary layer approach.

Jitender Madan1, Garima Chawla, Vinod Arora, Rajiv Malik, Arvind K Bansal.   

Abstract

The present study was performed to determine the relative contribution of both passive and nonpassive transport processes in jejunal absorption of gabapentin. The oral absorption of gabapentin was studied using in situ single pass intestinal perfusion technique in fasted rats. Unbiased intrinsic membrane absorption parameters such as maximal flux, Michaelis constant, carrier permeability, and membrane permeability were calculated using a modified boundary layer model. Gabapentin intestinal perfusion results indicate that its jejunal absorption in rats occurs via a nonpassive process, with no significant passive absorption component, as demonstrated by saturable absorption kinetics and its concentration-dependent permeability. A good correlation (r2 = 0.88) between observed human absorption fraction and calculated (from in situ rat intestine) human absorption fraction was obtained.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16146343      PMCID: PMC2751511          DOI: 10.1208/aapsj070121

Source DB:  PubMed          Journal:  AAPS J        ISSN: 1550-7416            Impact factor:   4.009


  17 in total

1.  Characterization of the oral absorption of several aminopenicillins: determination of intrinsic membrane absorption parameters in the rat intestine in situ.

Authors:  P J Sinko; G L Amidon
Journal:  Int J Pharm       Date:  1992-09-20       Impact factor: 5.875

2.  Rate-limited steps of human oral absorption and QSAR studies.

Authors:  Yuan H Zhao; Michael H Abraham; Joelle Le; Anne Hersey; Chris N Luscombe; Gordon Beck; Brad Sherborne; Ian Cooper
Journal:  Pharm Res       Date:  2002-10       Impact factor: 4.200

3.  Comparison of the gravimetric, phenol red, and 14C-PEG-3350 methods to determine water absorption in the rat single-pass intestinal perfusion model.

Authors:  S C Sutton; M T Rinaldi; K E Vukovinsky
Journal:  AAPS PharmSci       Date:  2001

4.  Estimating the fraction dose absorbed from suspensions of poorly soluble compounds in humans: a mathematical model.

Authors:  D M Oh; R L Curl; G L Amidon
Journal:  Pharm Res       Date:  1993-02       Impact factor: 4.200

5.  Generality in effects of transmucosal fluid movement and glucose on drug absorption from the rat small intestine.

Authors:  S Kitazawa; H Ito; I Johno; T Takahashi; H Takenaka
Journal:  Chem Pharm Bull (Tokyo)       Date:  1978-03       Impact factor: 1.645

6.  A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability.

Authors:  G L Amidon; H Lennernäs; V P Shah; J R Crison
Journal:  Pharm Res       Date:  1995-03       Impact factor: 4.200

7.  Pharmacokinetics and metabolism of gabapentin in rat, dog and man.

Authors:  K O Vollmer; A von Hodenberg; E U Kölle
Journal:  Arzneimittelforschung       Date:  1986-05

8.  Solvent drag effect in drug intestinal absorption. I. Studies on drug and D2O absorption clearances.

Authors:  A Karino; M Hayashi; T Horie; S Awazu; H Minami; M Hanano
Journal:  J Pharmacobiodyn       Date:  1982-06

9.  A saturable transport mechanism in the intestinal absorption of gabapentin is the underlying cause of the lack of proportionality between increasing dose and drug levels in plasma.

Authors:  B H Stewart; A R Kugler; P R Thompson; H N Bockbrader
Journal:  Pharm Res       Date:  1993-02       Impact factor: 4.200

10.  Transport of gabapentin, a gamma-amino acid drug, by system l alpha-amino acid transporters: a comparative study in astrocytes, synaptosomes, and CHO cells.

Authors:  T Z Su; E Lunney; G Campbell; D L Oxender
Journal:  J Neurochem       Date:  1995-05       Impact factor: 5.372

View more
  3 in total

1.  Simulations of the nonlinear dose dependence for substrates of influx and efflux transporters in the human intestine.

Authors:  Michael B Bolger; Viera Lukacova; Walter S Woltosz
Journal:  AAPS J       Date:  2009-05-12       Impact factor: 4.009

2.  In vivo and in vitro evaluations of intestinal gabapentin absorption: effect of dose and inhibitors on carrier-mediated transport.

Authors:  Malte Selch Larsen; Sidsel Frølund; Martha Kampp Nøhr; Carsten Uhd Nielsen; Mats Garmer; Mads Kreilgaard; René Holm
Journal:  Pharm Res       Date:  2014-09-03       Impact factor: 4.200

3.  Novel cationic supersaturable nanomicellar systems of raloxifene hydrochloride with enhanced biopharmaceutical attributes.

Authors:  Atul Jain; Rajpreet Kaur; Sarwar Beg; Varun Kushwah; Sanyog Jain; Bhupinder Singh
Journal:  Drug Deliv Transl Res       Date:  2018-06       Impact factor: 4.617

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.